Shire, Maker of Binge-Eating Drug Vyvanse, First Marketed the Disease by KATIE THOMAS

By KATIE THOMAS

The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.

Published: February 25, 2015 at 12:00AM

from NYT Business Day http://ift.tt/17uC4fV

from WordPress http://ift.tt/1vvKoXY

via Hadi Aboukhater